Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 249 Carcinoma, Non-Small-Cell Lung 227 Prostatic Neoplasms 117 Neoplasms 106 Multiple Myeloma 91 Neoplasm Metastasis 76 Colorectal Neoplasms 74 Parkinson Disease 4, Autosomal Dominant Lewy Body 69 Lung Neoplasms 67 Ovarian Neoplasms 61 Leukemia, Myeloid, Acute 50 Carcinoma, Hepatocellular 47 Melanoma 46 Leukemia, Lymphocytic, Chronic, B-Cell 44 Carcinoma, Renal Cell 44 Urinary Bladder Neoplasms 41 Triple Negative Breast Neoplasms 41 Stomach Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 41 Recurrence 41 Brain Neoplasms 40 Myasthenia Gravis 37 Small Cell Lung Carcinoma 35 Lymphoma, Follicular 35 Nasopharyngeal Carcinoma 34 Head and Neck Neoplasms 33 Pancreatic Neoplasms 32 Rectal Neoplasms 31 Lymphoma, Large B-Cell, Diffuse 30 Colonic Neoplasms 29

Interventions

ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 daclatasvir 1 Sofosbuvir 1 Simeprevir 1 Ribavirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis C, Chronic × 1 year × Clear all

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡